Liposome Technology Inc

Basic Information

1050 Hamilton Court
Menlo Park, CA, 94025

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. "STEALTH" LIPOSOME ENCAPSULATED HEMOGLOBIN--LOW TOXICITY BLOOD SUBSTITUTE

    Amount: $49,318.00

    THE OVERALL GOAL IS TO DEVELOP AN OXYGEN-CARRYING RED BLOOD CELL SUBSTITUTE TO REPLACE WHOLE BLOOD TRANSFUSIONS AND/OR AN OXYGEN-CARRYING PLASMA EXPANDER TO REPLACE PLASMA AND INTRAVENOUS FLUIDS USED ...

    SBIR Phase I 1992 Department of Health and Human Services
  2. DEVELOPMENT OF A LIPOSOME BASED INTRAMUSCULAR SUSTAINED RELE

    Amount: $500,000.00

    A LIPOSOME BASED SUSTAINED RELEASE DELIVERY SYSTEM FOR I.M. INJECTION OF WATER SOLUBLE DRUGS WAS DEVELOPED USING GENTAMICIN (I) AS A MODEL DRUG. THE PHARMACOKINETIC PROFILE OF (I) IN MICE, BIODEGRADAT ...

    SBIR Phase II 1986 Department of Health and Human Services
  3. DEVELOPMENT OF A LIPOSOME BASED INTRAMUSCULAR SUSTAINED RELE

    Amount: $49,769.00

    N/A

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government